1-9 of 9
Fang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Matthew D. Hellmann, Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich, Fang Wang, Jane B. Trepel, Min-Jung Lee, Akira Yuno, Sunmin Lee, Susan Brouwer, Serap Sankoh, Lei Wang, David Tamang, Emmett V. Schmidt, Michael L. Meyers, Suresh S. Ramalingam, Elaine Shum, Peter Ordentlich
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (4): 1019–1028.
https://doi.org/10.1158/1078-0432.CCR-20-3305
Published: 15 February 2021
View article titled, Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy
Open the PDF for Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy in another window
Includes: Supplementary data
Journal Articles

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL–Induced B-Cell Acute Lymphoblastic Leukemia

Linyu Yang, Qiang Qiu, Minghai Tang, Fang Wang, Yuyao Yi, Dongni Yi, Zhuang Yang, Zejiang Zhu, Shoujun Zheng, Jianhong Yang, Heying Pei, Li Zheng, Yong Chen, Liping Gou, Liya Luo, Xing Deng, Haoyu Ye, Yiguo Hu, Ting Niu, Lijuan Chen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (24): 7527–7539.
https://doi.org/10.1158/1078-0432.CCR-19-0516
Published: 13 December 2019
View article titled, Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of <em>BCR-ABL</em>–Induced B-Cell Acute Lymphoblastic Leukemia
Open the PDF for Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of <em>BCR-ABL</em>–Induced B-Cell Acute Lymphoblastic Leukemia in another window
Includes: Supplementary data
Journal Articles

Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

George A. Dominguez, Thomas Condamine, Sridevi Mony, Ayumi Hashimoto, Fang Wang, Qin Liu, Andres Forero, Johanna Bendell, Robert Witt, Neil Hockstein, Prasanna Kumar, Dmitry I. Gabrilovich
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 2942–2950.
https://doi.org/10.1158/1078-0432.CCR-16-1784
Published: 14 June 2017
View article titled, Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
Open the PDF for Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody in another window
Includes: Supplementary data
Journal Articles

Enhanced Antitumor Activity of an Anti-5T4 Antibody–Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes

Boris Shor, Jennifer Kahler, Maureen Dougher, Jane Xu, Michelle Mack, Ed Rosfjord, Fang Wang, Eugene Melamud, Puja Sapra
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (2): 383–394.
https://doi.org/10.1158/1078-0432.CCR-15-1166
Published: 14 January 2016
View article titled, Enhanced Antitumor Activity of an Anti-5T4 Antibody–Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes
Open the PDF for Enhanced Antitumor Activity of an Anti-5T4 Antibody–Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes in another window
Includes: Supplementary data
Journal Articles

EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

Yu-Hong Li, Fang Wang, Lin Shen, Yan-Ming Deng, Qiong Shao, Fen Feng, Xin An, Feng-Hua Wang, Zhi-Qiang Wang, Rui-Hua Xu, Jian-Yong Shao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 382–390.
https://doi.org/10.1158/1078-0432.CCR-10-0208
Published: 16 January 2011
View article titled, <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
Open the PDF for <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence

Fang Wang, Jing Ren, Xiu-Chun Qiu, Li-Feng Wang, Qing Zhu, Ying-Qi Zhang, Yi Huan, Yan-Ling Meng, Li-Bo Yao, Si-Yi Chen, Yan-Ming Xu, An-Gang Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2284–2294.
https://doi.org/10.1158/1078-0432.CCR-09-2367
Published: 14 April 2010
View article titled, Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence
Open the PDF for Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence in another window
Includes: Supplementary data
Journal Articles

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Callum M. Sloss, Fang Wang, Rong Liu, Lijun Xia, Michael Houston, David Ljungman, Michael A. Palladino, James C. Cusack, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5116–5123.
https://doi.org/10.1158/1078-0432.CCR-07-4506
Published: 12 August 2008
View article titled, Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells
Open the PDF for Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells in another window
Journal Articles

Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1

Yu Fang Wang, Chen Chen Jiang, Kelly Anne Kiejda, Susan Gillespie, Xu Dong Zhang, Peter Hersey
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4934–4942.
https://doi.org/10.1158/1078-0432.CCR-07-0665
Published: 15 August 2007
View article titled, Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1
Open the PDF for Apoptosis Induction in Human Melanoma Cells by Inhibition of MEK Is Caspase-Independent and Mediated by the Bcl-2 Family Members PUMA, Bim, and Mcl-1 in another window
Journal Articles

Circulating Hepatitis B Virus Nucleic Acids in Chronic Infection : Representation of Differently Polyadenylated Viral Transcripts during Progression to Nonreplicative Stages

Qin Su, Shu-Fang Wang, Tian-En Chang, Raoul Breitkreutz, Holger Hennig, Kunio Takegoshi, Lutz Edler, Claus H. Schröder
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (7): 2005–2015.
Published: 01 July 2001
View article titled, Circulating Hepatitis B Virus Nucleic Acids in Chronic Infection : <subtitle>Representation of Differently Polyadenylated Viral Transcripts during Progression to Nonreplicative Stages</subtitle>
Open the PDF for Circulating Hepatitis B Virus Nucleic Acids in Chronic Infection : <subtitle>Representation of Differently Polyadenylated Viral Transcripts during Progression to Nonreplicative Stages</subtitle> in another window